Evaluating the Long-Term Safety and Tolerability of Efgartigimod PH20 SC Administered Subcutaneously in Patients With Generalized Myasthenia Gravis

NCT04818671 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
184
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

argenx